684 top medical experts on Tuberous Sclerosis across 45 countries and 38 U.S. states, including 639 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Tuberous Sclerosis: Autosomal dominant neurocutaneous syndrome classically characterized by mental retardation; epilepsy; and skin lesions (e.g., adenoma sebaceum and hypomelanotic macules). There is, however, considerable heterogeneity in the neurologic manifestations. It is also associated with cortical tuber and hamartomas formation throughout the body, especially the heart, kidneys, and eyes. Mutations in two loci TSC1 and TSC2 that encode hamartin and tuberin, respectively, are associated with the disease.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Group I Malformations of Cortical Development (328), Hamartoma (963), Hereditary Neoplastic Syndromes (1,050), Multiple Primary Neoplasms (1,921), Nervous System Heredodegenerative Disorders (409), Neurocutaneous Syndromes (984).
  4. Clinical Trials ClinicalTrials.gov : at least 55 including 3 Active, 26 Completed, 16 Recruiting
  5. Synonyms: Bourneville Disease, Epiloia, Bourneville Phakomatosis


  

        

                    


    Computing Expert Listing ...

);